Insider · CIK 0001676170

Coloma Jason V

Reports to the SEC for 3 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001676170

Forms 4 and 5

Insider transactions

31 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,593 sh	$27.02	−$70.1K	15,558
2026-10-01	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−31.9K sh	$27.02	−$862K	191,447
2026-09-03	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−129 sh	$25.77	−$3,324.962	27,362
2026-09-03	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−11.3K sh	$26.01	−$293K	27,491
2026-09-02	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−9,852 sh	$26.38	−$260K	40,148
2026-09-02	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,375 sh	$27.12	−$37.3K	38,773
2026-09-01	MAZEMaze Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−50K sh	—	—	50,000
2026-09-01	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,593 sh	$26.31	−$68.2K	18,151
2026-09-01	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−31.9K sh	$26.29	−$839K	223,355
2026-09-01	MAZEMaze Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+50K sh	—	—	50,000
2026-08-03	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,604 sh	$27.09	−$43.4K	255,263
2026-08-03	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,439 sh	$26.71	−$65.2K	20,898
2026-08-03	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−154 sh	$27.09	−$4,172.476	20,744
2026-08-03	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−30.3K sh	$26.71	−$810K	256,867
2026-07-01	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,597 sh	$30.44	−$48.6K	287,171
2026-07-01	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,593 sh	$29.98	−$77.7K	23,337
2026-07-01	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−30.3K sh	$29.95	−$908K	288,768
2026-06-23	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−23.9K sh	$26.05	−$622K	319,079
2026-06-22	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,953 sh	$26.00	−$50.8K	342,944
2026-06-22	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,040 sh	$26.00	−$53K	25,930
2026-06-01	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−6,090 sh	$26.20	−$160K	344,897
2026-06-01	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−553 sh	$26.24	−$14.5K	27,970
2026-05-26	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−25.6K sh	$26.02	−$666K	350,987
2026-05-22	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,504 sh	$26.00	−$117K	376,569
2026-05-22	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,478 sh	$26.00	−$64.4K	28,523
2026-05-15	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,822 sh	$26.00	−$47.4K	381,073
2026-05-15	MAZEMaze Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−116 sh	$26.00	−$3,016	31,001
2026-03-02	MAZEMaze Therapeutics, Inc. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+75K sh	—	—	75,000
2026-03-02	MAZEMaze Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+150K sh	—	—	150,000
2025-09-22	MAZEMaze Therapeutics, Inc. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	100,000
2016-06-08	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	SVP, Chief Business Officer	AAward	+200K sh	—	—	200,000

Recent filings

Accepted (ET)
Oct 24
Coloma Jason V0001676170-26-000024
SEC(opens sec.gov)
Sep 44
Coloma Jason V0001676170-26-000022
SEC(opens sec.gov)
Sep 34
Coloma Jason V0001676170-26-000020
SEC(opens sec.gov)
Aug 54
Coloma Jason V0001676170-26-000016
SEC(opens sec.gov)
Jul 24
Coloma Jason V0001676170-26-000014
SEC(opens sec.gov)
Jun 244
Coloma Jason V0001676170-26-000012
SEC(opens sec.gov)

Companies

Address

C/O MAZE THERAPEUTICS, INC. 171 OYSTER POINT BOULEVARD, SUITE 300

SOUTH SAN FRANCISCO, CA, 94080